Amy Emerson, Lykos Therapeutics CEO

Psy­che­del­ic-as­sist­ed drug de­vel­op­er MAPS PBC nabs $100M, re­names to Lykos Ther­a­peu­tics

MAPS Pub­lic Ben­e­fit Cor­po­ra­tion, a Cal­i­for­nia biotech at­tempt­ing to bring MD­MA-as­sist­ed ther­a­py to mar­ket for men­tal health con­di­tions, said it has raised more than …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.